22157.jpg
Amyotrophic Lateral Sclerosis Opportunity Assessment and Forecasts 2019-2024 & 2024-2029 - Focus on US, France, Germany, Italy, Spain, UK, Japan and Canada
July 17, 2024 09:47 ET | Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update" report has been added to ResearchAndMarkets.com's offering.This...
U.S. Hereditary Angioedema Therapeutics Market
United States Hereditary Angioedema Therapeutics Market Soars to New Heights, Projections to 2029
July 16, 2024 11:22 ET | Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to...
Global Glucosamine Market
Global Glucosamine Business Analysis Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023 - Emerging Markets and Growth Opportunities in Developing Regions
July 15, 2024 05:31 ET | Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Glucosamine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Glucosamine is...
22157.jpg
Acute Graft-Versus-Host Disease Pipeline Research 2024 Featuring MaaT Pharma, Medac, CSL Behring, Humanigen, Ironwood Pharmaceuticals, ReAlta Life Sciences, Roche, and Incyte
June 26, 2024 09:34 ET | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Acute Graft-Versus-Host Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Acute...
U.S. Inflammatory Bowel Disease Treatment Market
U.S. Inflammatory Bowel Disease Treatment Market Trends Analysis Report 2024-2030 Featuring Biogen, Novartis, Eli Lilly & Co, UCB, Celltrion, Merck & Co, and Johnson & Johnson
June 25, 2024 10:57 ET | Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution...
22157.jpg
$10.9 Billion Attention Deficit Hyperactivity Disorder (ADHD) Opportunity Assessment and Forecasts 2022-2024 & 2032: Epidemiology, Symptoms, Diagnosis, Disease Management, Revenue, Unmet Needs
June 20, 2024 04:20 ET | Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032" report has been added to ResearchAndMarkets.com's...
22157.jpg
Fibromyalgia Drug Pipeline Landscape Report 2024 Featuring Tonix Pharmaceuticals, Virios Therapeutics, Tryp Therapeutics, Axsome Therapeutics, Scilex, Silo Pharma,& UCB Biopharma
June 17, 2024 07:33 ET | Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Fibromyalgia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This Report provides comprehensive insights...
22157.jpg
Endometriosis Drug Pipeline Landscape 2024: Insights About 15+ Companies and 20+ Pipeline Drugs
June 17, 2024 06:54 ET | Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Endometriosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Global Monoclonal Antibodies Market
Global Monoclonal Antibodies Market Report 2024-2032, by Production Method, Source, Indication, End Use and Region
June 12, 2024 11:25 ET | Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2024-2032" report has been added to ...
Blau Syndrome Market
Blau Syndrome Market Report 2024-2034: Epidemiology, Industry Trends, Share, Size and Growth Forecast
June 12, 2024 10:45 ET | Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Blau Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...